|
Volumn 67, Issue 12, 2008, Pages 1791-1792
|
A polymorphism in the gene encoding the Fcγ IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD16 ANTIGEN;
FC GAMMA R III A;
INFLIXIMAB;
UNCLASSIFIED DRUG;
ADULT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DNA DETERMINATION;
DNA POLYMORPHISM;
FEMALE;
GENOTYPE;
HUMAN;
JAPAN;
LETTER;
MALE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
TREATMENT RESPONSE;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
FEMALE;
GENETIC MARKERS;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RECEPTORS, IGG;
TREATMENT OUTCOME;
|
EID: 56749168819
PISSN: 00034967
EISSN: 14682060
Source Type: Journal
DOI: 10.1136/ard.2007.086892 Document Type: Letter |
Times cited : (16)
|
References (4)
|